Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.1 (
sulfatase
)
3,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 10-year-old boy with juvenile metachromatic leukodystrophy (MLD) presented with the 459 + 1G-->A arylsulfatase A (ASA) mutation on one allele. To detect his complete genotype, the other
ASA
allele was sequenced and a T-to-C transition at nucleotide 376 in exon 2 was identified. This missense mutation results in a substitution of leucine 76 by proline. Of 20 MLD unrelated controls, 18 carried the L/
P76
mutation either in the homozygous (n = 6) or heterozygous (n = 12) state. The presence or absence of L/
P76
did not influence leukocyte
ASA
activity or urinary sulfatide excretion. Apparently, the substitution of leucine 76 by proline is a common
ASA
polymorphism, neither being related to MLD nor creating
ASA
pseudodeficiency. However, because of its frequency and location, L/
P76
may be of particular importance in genetic studies requiring the differentiation of the
ASA
alleles within a kindred. Further studies are directed to the as yet unresolved genotype of the index case with juvenile MLD.
...
PMID:A new polymorphism of arylsulfatase A within the coding region. 870 8